Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E William St Clair

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
The Journal of Rheumatology. Supplement|September 19, 2002
Tides of inflammation: impact of biologicsE William St Clair
Current Opinion in Immunology|October 16, 2009
Novel targeted therapies for autoimmunityE William St Clair
The Journal of Clinical Investigation|March 22, 2008
The calm after the cytokine storm: lessons from the TGN1412 trialE William St Clair
Best Practice & Research. Clinical Rheumatology|August 14, 2003
Treatment of early rheumatoid arthritisRobin Geletka, E William St Clair
Rheumatic Diseases Clinics of North America|March 1, 2006
New therapeutics in rheumatoid arthritisChristine Savage, E William St Clair
The Journal of Allergy and Clinical Immunology|January 22, 2008
B cell-directed therapies for autoimmune disease and correlates of disease response and relapseMarc C Levesque, E William St Clair
Current Opinion in Rheumatology|May 1, 2002
Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseasesLisa G Criscione, E William St Clair
Current Opinion in Rheumatology|February 24, 2026
Revisiting the CD40-CD40L axis: from mechanistic insight to therapeutic renewal in autoimmune diseaseSonali J Bracken, E William St Clair
F1000Research|September 12, 2019
Recent advances in the search for a targeted immunomodulatory therapy for primary Sjögren's syndromeDavid L Leverenz, E William St Clair
Expert Opinion on Biological Therapy|April 19, 2005
Infliximab for the treatment of early rheumatoid arthritisRobin C Geletka, E William St Clair
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Rheumatology. Supplement|September 19, 2002
Tides of inflammation: impact of biologicsE William St Clair
Current Opinion in Immunology|October 16, 2009
Novel targeted therapies for autoimmunityE William St Clair
The Journal of Clinical Investigation|March 22, 2008
The calm after the cytokine storm: lessons from the TGN1412 trialE William St Clair
Best Practice & Research. Clinical Rheumatology|August 14, 2003
Treatment of early rheumatoid arthritisRobin Geletka, E William St Clair
Rheumatic Diseases Clinics of North America|March 1, 2006
New therapeutics in rheumatoid arthritisChristine Savage, E William St Clair
The Journal of Allergy and Clinical Immunology|January 22, 2008
B cell-directed therapies for autoimmune disease and correlates of disease response and relapseMarc C Levesque, E William St Clair
Current Opinion in Rheumatology|May 1, 2002
Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseasesLisa G Criscione, E William St Clair
Current Opinion in Rheumatology|February 24, 2026
Revisiting the CD40-CD40L axis: from mechanistic insight to therapeutic renewal in autoimmune diseaseSonali J Bracken, E William St Clair
F1000Research|September 12, 2019
Recent advances in the search for a targeted immunomodulatory therapy for primary Sjögren's syndromeDavid L Leverenz, E William St Clair
Expert Opinion on Biological Therapy|April 19, 2005
Infliximab for the treatment of early rheumatoid arthritisRobin C Geletka, E William St Clair
Pageof 13